Strategic Alliance, Shaping the Future: Jiagene Medical and Medtronic Launch Robotic-Guided MRgLITT Therapy

Genlight Neurotech and Medtronic Kanghui Joint Release Ceremony at the 8th CIIE

On the open stage of the 8th China International Import Expo,GenLight MedicalAndMedtronic KanghuiJointly released "Robot-Guided Laser Ablation Minimally Invasive Technology", marking a new stage of intelligent and precise minimally invasive treatment in neurosurgery.

This collaboration represents not only a fusion of technologies but also a co-construction of ecosystems. The LaserRO™ dual-wavelength MRI-guided laser ablation system, innovatively launched by Genlight Neurotech, together with Medtronic's Stealth Autoguide neurosurgical robot and Midas Rex.High-Speed Power SystemStrong Alliance Builds a Complete Surgical Closed Loop from "Precision Navigation" to "Intelligent Ablation"

MRgLITT, or Magnetic Resonance-guided Laser Interstitial Thermal Therapy (LITT), is an advanced minimally invasive surgical technique. It delivers laser energy precisely to intracranial lesions through ultra-thin fiber optic kits and completes thermal ablation of the diseased tissue under real-time MRI monitoring. It is widely used in the treatment of complex conditions such as drug-resistant epilepsy, gliomas, and radiation necrosis.

GenLight LaserRO™Magnetic Resonance-Guided Laser AblationSystem Schematic Diagram

The Medtronic AiBLE™ Digital Ecosystem, with its exceptional preoperative planning capabilities, high-precision robotic execution platform, and real-time visualization navigation system, has infused LITT technology with a stronger "intelligent gene":

Preoperative Planning:Based on CSD neural fiber tracking, construct a "safe pathway" that integrates anatomical and functional information;

Intraoperative Execution:The robot achieves sub-millimeter precision implantation, maximizing the protection of normal brain tissue;

Ablation Validation:Dual-wavelength laser ablation system combined with real-time MRI monitoring achieves "visible, controllable, and verifiable" personalized treatment.

Medtronic AiBLE™ is not just a technology platform, but also an intelligent surgical ecosystem that continuously evolves and fosters symbiotic collaboration. By unifying device languages and integrating treatment pathways, it achieves a leap from "spatial understanding" to "physiological understanding," enabling the system to truly "comprehend tissue" and understand "the logic of life behind lesions."

The core of the AiBLE™ ecosystem lies not in connecting numerous devices, but in understanding more clinical scenarios; not in being compatible with all technologies, but in growing together with partners. GenLight is an important innovative force within this ecosystem.